Ebola virion attachment and entry into human Macrophages profoundly effects early cellular gene expression

PLoS Neglected Tropical Diseases

Volumn 5, Issue 10, 2011, Pages

  Wahl Jensen, Victoria ^a,b,c   Kurz, Sabine ^d   Feldmann, Friedericke ^b,e   Buehler, Lukas K ^f   Kindrachuk, Jason ^a   DeFilippis, Victor ^g   da Silva Correia, Jean ^d   Früh, Klaus ^g   Kuhn, Jens H ^a   Burton, Dennis R ^d,h   Feldmann, Heinz ^b,c,e  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Public Health Agency of Canada   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f Southwestern College   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^h MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN GP 1 2; MESSENGER RNA; PROTEIN VP40; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; EMBRYO; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; NONHUMAN; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VIRION; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS LIKE AGENT; CELL CULTURE; GENE EXPRESSION REGULATION; IMMUNOLOGY; MACROPHAGE; MICROARRAY ANALYSIS; PATHOGENICITY; REAL TIME POLYMERASE CHAIN REACTION; VIROLOGY;

CELLS, CULTURED; EBOLAVIRUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGES; MICROARRAY ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; VIRION; VIRUS INTERNALIZATION;

EID: 80055084611     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001359     Document Type: Article

References (53)

1. Feldmann H, Geisbert TW, Jahrling PB, Klenk HD, Netesov SV, et al. (2005) Filoviridae. In: Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA, editors. Virus Taxonomy, VIIIth Report of the ICTV London Elsevier pp. 645-653.
2. Johnson KM, Webb PA, Lange JV, Murphy FA, (1977) Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet 309: 569-571.
3. Kuhn JH, (2008) Filoviruses. A compendium of 40 years of epidemiological, clinical, and laboratory studies. Arch Virol Suppl 20: 13-360.
4. Geisbert TW, Young HA, Jahrling PB, Davis KJ, Larsen T, et al. (2003) Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am J Pathol 163: 2371-2382.
5. Geisbert TW, Hensley LE, Larsen T, Young HA, Reed DS, et al. (2003) Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 163: 2347-2370.
6. Villinger F, Rollin PE, Brar SS, Chikkala NF, Winter J, et al. (1999) Markedly Elevated Levels of Interferon (IFN)-γ, IFN-α, Interleukin (IL)-2, IL-10, and Tumor Necrosis Factor-α Associated with Fatal Ebola Virus Infection. The Journal of Infectious Diseases- Official Publication of the Infectious Diseases Society of America (Chicago) 179 (suppl. 1): S188-S191.
7. Baize S, Leroy EM, Georges-Courbot MC, Capron M, Lansoud-Soukate J, et al. (1999) Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 5: 423-426.
8. Leroy EM, Baize S, Volchkov VE, Fisher-Hoch SP, Georges-Courbot MC, et al. (2000) Human asymptomatic Ebola infection and strong inflammatory response. Lancet 355: 2210-2215.
9. Baize S, Leroy EM, Georges AJ, Georges-Courbot MC, Capron M, et al. (2002) Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol 128: 163-168.
10. Leroy EM, Baize S, Debre P, Lansoud-Soukate J, Mavoungou E, (2001) Early immune responses accompanying human asymptomatic Ebola infections. Clin Exp Immunol 124: 453-460.
11. Wauquier N, Becquart P, Padilla C, Baize S, Leroy EM, (2010) Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis 4.
12. Zaki SR, Shieh WJ, Greer PW, Goldsmith CS, Ferebee T, et al. (1999) A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 179 (Suppl 1): S36-47.
13. Geisbert TW, Young HA, Jahrling PB, Davis KJ, Kagan E, et al. (2003) Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis 188: 1618-1629.
14. Schnittler HJ, Feldmann H, (1998) Marburg and Ebola hemorrhagic fevers: does the primary course of infection depend on the accessibility of organ-specific macrophages? Clin Infect Dis 27: 404-406.
15. Ryabchikova EI, Kolesnikova LV, Luchko SV, (1999) An analysis of features of pathogenesis in two animal models of Ebola virus infection. J Infect Dis 179 (Suppl 1): S199-202.
16. Ströher U, West E, Bugany H, Klenk H-D, Schnittler H-J, et al. (2001) Infection and activation of monocytes by Marburg and Ebola viruses. J Virol 75: 11025-11033.
17. Gibb TR, Norwood DA Jr, Woollen N, Henchal EA, (2002) Viral replication and host gene expression in alveolar macrophages infected with Ebola virus (Zaire strain). Clin Diagn Lab Immunol 9: 19-27.
18. Gupta M, Mahanty S, Ahmed R, Rollin PE, (2001) Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro. Virology 284: 20-25.
19. Wahl-Jensen V, Kurz SK, Hazelton PR, Schnittler H-J, Ströher U, et al. (2005) Role of Ebola Virus Secreted Glycoproteins and Virus-Like Particles in Activation of Human Macrophages. J Virol 79: 2413-2419.
20. Kato-Maeda M, Gao Q, Small PM, (2001) Microarray analysis of pathogens and their interaction with hosts. Cell Microbiol 3: 713-719.
21. Manger ID, Relman DA, (2000) How the host 'sees' pathogens: global gene expression responses to infection. Curr Opin Immunol 12: 215-218.
22. Cummings CA, Relman DA, (2000) Using DNA microarrays to study host-microbe interactions. Emerg Infect Dis 6: 513-525.
23. Tan SL, Ganji G, Paeper B, Proll S, Katze MG, (2007) Systems biology and the host response to viral infection. Nature biotechnology 25: 1383-1389.
24. Katze MG, Fornek JL, Palermo RE, Walters KA, Korth MJ, (2008) Innate immune modulation by RNA viruses: emerging insights from functional genomics. Nature reviews Immunology 8: 644-654.
25. Moe JB, Lambert RD, Lupton HW, (1981) Plaque Assay for Ebola virus. J Clin Microbiol 13: 791-793.
26. Hazelton PR, Coombs KM, (1999) The reovirus mutant tsA279 L2 gene is associated with generation of a spikeless core particle: implications for capsid assembly. J Virol 73: 2298-2308.
27. Eisen MB, Spellman PT, Brown PO, Botstein D, (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868.
28. Lynn DJ, Winsor GL, Chan C, Richard N, Laird MR, et al. (2008) InnateDB: facilitating systems-level analyses of the mammalian innate immune response. Molecular systems biology 4: 218.
29. Yuen T, Wurmbach E, Pfeffer RL, Ebersole BJ, Sealfon SC, (2002) Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res 30: e48.
30. Kuhn JH, Radoshitzky SR, Guth AC, Warfield KL, Li W, et al. (2006) Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J Biol Chem 281: 15951-15958.
31. Manicassamy B, Wang J, Jiang H, Rong L, (2005) Comprehensive analysis of ebola virus GP1 in viral entry. J Virol 79: 4793-4805.
32. Bavari S, Bosio CM, Wiegand E, Ruthel G, Will AB, et al. (2002) Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med 195: 593-602.
33. Noda T, Sagara H, Suzuki E, Takada A, Kida H, et al. (2002) Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol 76: 4855-4865.
34. Okumura A, Pitha PM, Yoshimura A, Harty RN, (2010) Interaction between Ebola virus glycoprotein and host toll-like receptor 4 leads to induction of proinflammatory cytokines and SOCS1. Journal of virology 84: 27-33.
35. Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, Muhlberger E, et al. (2003) The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol 77: 7945-7956.
36. Basler CF, Wang X, Muhlberger E, Volchkov V, Paragas J, et al. (2000) The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A 97: 12289-12294.
37. Cardenas WB, Loo YM, Gale M Jr, Hartman AL, Kimberlin CR, et al. (2006) Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol 80: 5168-5178.
38. Feng Z, Cerveny M, Yan Z, He B, (2007) The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR. J Virol 81: 182-192.
39. Prins KC, Cardenas WB, Basler CF, (2009) Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. J Virol 83: 3069-3077.
40. Reid SP, Leung LW, Hartman AL, Martinez O, Shaw ML, et al. (2006) Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J Virol 80: 5156-5167.
41. Mateo M, Reid SP, Leung LW, Basler CF, Volchkov VE, (2010) Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling. J Virol 84: 1169-1175.
42. Haasnoot J, de Vries W, Geutjes EJ, Prins M, de Haan P, et al. (2007) The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog 3: e86.
43. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, et al. (2003) DNA deamination mediates innate immunity to retroviral infection. Cell 113: 803-809.
44. Perron MJ, Stremlau M, Song B, Ulm W, Mulligan RC, et al. (2004) TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc Natl Acad Sci U S A 101: 11827-11832.
45. Neil SJ, Zang T, Bieniasz PD, (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451: 425-430.
46. Weidner JM, Jiang D, Pan XB, Chang J, Block TM, et al. (2010) Interferon-Induced Cell Membrane Proteins, IFITM3 and Tetherin, Inhibit Vesicular Stomatitis Virus Infection via Distinct Mechanisms. J Virol 84: 12646-12657.
47. Radoshitzky SR, Dong L, Chi X, Clester JC, Retterer C, et al. (2010) Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin. J Virol 84: 10569-10580.
48. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, et al. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243-1254.
49. Huang ICea (2011) IFITM proteins restrict cathepsin-dependent entry of Marburg virus, Ebola virus, and SARS coronavirus. PLoS Pathog In press.
50. Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, et al. (2005) Fruit bats as reservoirs of Ebola virus. Nature 438: 575-576.
51. Towner JS, Amman BR, Sealy TK, Carroll SA, Comer JA, et al. (2009) Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog 5: e1000536.
52. Spurgers KB, Alefantis T, Peyser BD, Ruthel GT, Bergeron AA, et al. (2010) Identification of Essential Filovirion-associated Host Factors by Serial Proteomic Analysis and RNAi Screen. Mol Cell Proteomics 9: 2690-2703.
53. Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, et al. (2004) The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 32: D258-261.